1
|
Dannehl D, Jakob D, Mergel F, Estler A, Engler T, Volmer L, Frevert ML, Matovina S, Englisch A, Tegeler CM, Rohner A, Seller A, Hahn M, Pfister K, Fink A, Popp I, Lorenz S, Tabatabai G, Juhasz-Böss I, Janni W, Brucker S, Taran FA, Hartkopf A, Schäffler H. The efficacy of sacituzumab govitecan and trastuzumab deruxtecan on stable and active brain metastases in metastatic breast cancer patients-a multicenter real-world analysis. ESMO Open 2024; 9:102995. [PMID: 38636292 PMCID: PMC11039313 DOI: 10.1016/j.esmoop.2024.102995] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2024] [Revised: 02/22/2024] [Accepted: 03/11/2024] [Indexed: 04/20/2024] Open
Abstract
BACKGROUND Fifteen to thirty percent of all patients with metastatic breast cancer (MBC) develop brain metastases (BCBMs). Recently, the antibody-drug conjugates (ADCs) sacituzumab govitecan (SG) and trastuzumab deruxtecan (T-DXd) have shown to be highly effective in the treatment of MBC. However, there are only limited data whether these macromolecules are also effective in patients with BCBMs. We therefore aimed to examine the efficacy of SG and T-DXd in patients with stable and active BCBMs in a multicenter real-world analysis. PATIENTS AND METHODS Female patients with stable or active BCBMs who were treated with either SG or T-DXd at three breast centers in Germany before 30 June 2023 were included. As per local clinical praxis, chemotherapy efficacy was evaluated by whole-body computed tomography and cranial magnetic resonance imaging at baseline and at least every 3 months according to local standards. Growth dynamics of BCBMs were assessed by board-certified neuroradiologists. RESULTS Of 26 patients, with a median of 2.5 prior therapy lines in the metastatic setting (range 2-15), 12 (43%) and 16 (57%) patients received SG and T-DXd, respectively. Out of the 12 patients who received SG, 2 (17%) were subsequently treated with T-DXd. Five out of 12 (42%) and 5 out of 16 (31%) patients treated with SG and T-DXd, respectively, had active BCBMs at treatment initiation. The intracranial disease control rate was 42% [95% confidence interval (CI) 13% to 71%] for patients treated with SG and 88% (95% CI 72% to 100%) for patients treated with T-DXd. After a median follow-up of 12.7 months, median intracranial progression-free survival was 2.7 months (95% CI 1.6-10.5 months) for SG and 11.2 months (95% CI 7.5-23.7 months) for T-DXd. CONCLUSIONS SG and T-DXd showed promising clinical activity in both stable and active BCBMs. Further prospective clinical studies designed to investigate the efficacy of modern ADCs on active and stable BCBMs are urgently needed.
Collapse
Affiliation(s)
- D Dannehl
- Department of Women's Health, Tuebingen University, Tuebingen.
| | - D Jakob
- Department of Gynecology and Obstetrics, University Medical Center Freiburg, Freiburg
| | - F Mergel
- Department of Gynecology and Obstetrics, Ulm University, Ulm
| | - A Estler
- Department of Radiology, Section for Diagnostic and Interventional Neuroradiology, Tuebingen
| | - T Engler
- Department of Women's Health, Tuebingen University, Tuebingen
| | - L Volmer
- Department of Women's Health, Tuebingen University, Tuebingen
| | - M-L Frevert
- Department of Gynecology and Obstetrics, University Medical Center Freiburg, Freiburg
| | - S Matovina
- Department of Women's Health, Tuebingen University, Tuebingen
| | - A Englisch
- Department of Women's Health, Tuebingen University, Tuebingen
| | - C M Tegeler
- Department of Women's Health, Tuebingen University, Tuebingen
| | - A Rohner
- Department of Women's Health, Tuebingen University, Tuebingen
| | - A Seller
- Department of Women's Health, Tuebingen University, Tuebingen
| | - M Hahn
- Department of Women's Health, Tuebingen University, Tuebingen
| | - K Pfister
- Department of Gynecology and Obstetrics, Ulm University, Ulm
| | - A Fink
- Department of Gynecology and Obstetrics, Ulm University, Ulm
| | - I Popp
- Department of Radiation Oncology, University Medical Center Freiburg, Freiburg
| | - S Lorenz
- Department of Radiology, Ulm University, Ulm
| | - G Tabatabai
- Center for Neurooncology, Comprehensive Cancer Center, Tuebingen University, Tuebingen, Germany
| | - I Juhasz-Böss
- Department of Gynecology and Obstetrics, University Medical Center Freiburg, Freiburg
| | - W Janni
- Department of Gynecology and Obstetrics, Ulm University, Ulm
| | - S Brucker
- Department of Women's Health, Tuebingen University, Tuebingen
| | - F-A Taran
- Department of Gynecology and Obstetrics, University Medical Center Freiburg, Freiburg
| | - A Hartkopf
- Department of Women's Health, Tuebingen University, Tuebingen; Department of Gynecology and Obstetrics, Ulm University, Ulm
| | - H Schäffler
- Department of Gynecology and Obstetrics, Ulm University, Ulm
| |
Collapse
|
2
|
Jochmann J, Fink A, Stella A, Feldmann R, Kramer L, Posch C. Prevention of severe immune-related colitis caused by combined immune checkpoint inhibition using vedolizumab: A case report. J Eur Acad Dermatol Venereol 2023. [PMID: 36913261 DOI: 10.1111/jdv.19028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/23/2023] [Accepted: 03/08/2023] [Indexed: 03/14/2023]
Affiliation(s)
- J Jochmann
- Department of Dermatology, Klinik Hietzing, Vienna, Austria
| | - A Fink
- Department of Dermatology, Klinik Hietzing, Vienna, Austria
| | - A Stella
- Department of Dermatology, Klinik Hietzing, Vienna, Austria
| | - R Feldmann
- Department of Dermatology, Klinik Hietzing, Vienna, Austria
| | - L Kramer
- Department of Gastroenterology, Klinik Hietzing, Vienna, Austria
| | - C Posch
- Department of Dermatology, Klinik Hietzing, Vienna, Austria
- Faculty of Medicine, Sigmund Freud University Vienna, Vienna, Austria
- Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, Munich, Germany
| |
Collapse
|
3
|
Pirker R, Fink A, Stella A, Stifter L, Posch C. Hyperprogression of Merkel cell carcinoma after avelumab treatment. J Eur Acad Dermatol Venereol 2023; 37:e675-e677. [PMID: 36662601 DOI: 10.1111/jdv.18887] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2022] [Accepted: 01/16/2023] [Indexed: 01/21/2023]
Affiliation(s)
- R Pirker
- Department of Dermatology, Klinik Hietzing, Vienna, Austria
| | - A Fink
- Department of Dermatology, Klinik Hietzing, Vienna, Austria
| | - A Stella
- Department of Dermatology, Klinik Hietzing, Vienna, Austria
| | - L Stifter
- Department of Pathology, Klinik Hietzing, Vienna, Austria
| | - C Posch
- Department of Dermatology, Klinik Hietzing, Vienna, Austria.,Faculty of Medicine, Sigmund Freud University Vienna, Vienna, Austria.,Department of Dermatology and Allergy, School of Medicine, Technical University of Munich, München, Germany
| |
Collapse
|
4
|
Bernard M, Hoffmann L, Gebhard B, Völlm C, Fink A, Richter M. Entwicklung und psychometrische Testung eines
Partizipationsmessinstruments für Jugendliche mit und ohne
körperlich-motorische Beeinträchtigungen und/oder
chronische Erkrankungen – Ergebnisse der PartJu
Pilotstudie. Das Gesundheitswesen 2022. [DOI: 10.1055/s-0042-1753606] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- M Bernard
- Martin-Luther Universität Halle-Wittenberg, Institut
für Medizinische Soziologie, Halle, Deutschland
| | - L Hoffmann
- Martin-Luther Universität Halle-Wittenberg, Institut
für Medizinische Soziologie, Halle, Deutschland
| | - B Gebhard
- Fachhoschule Südwestfalen, Fachbereich Bildungs- und
Gesellschaftswissenschaften, Soest, Deutschland
| | - C Völlm
- Fachhoschule Südwestfalen, Fachbereich Bildungs- und
Gesellschaftswissenschaften, Soest, Deutschland
| | - A Fink
- Kreis Groß-Gerau, Abteilung für Gesundheit und
Verbraucherschutz, Groß-Gerau, Deutschland
| | - M Richter
- Technische Universität München, Department of Sport and
Health Sciences, München, Deutschland
| |
Collapse
|
5
|
Healy K, Weise S, Fink A, Frese T, Knöchelmann A. Lerntypen unter Menschen mit Typ 2 Diabetes: Eine Aufteilung nach
sozioökonomischem Status. Das Gesundheitswesen 2022. [DOI: 10.1055/s-0042-1753652] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- K Healy
- Medizinische Fakultät der Martin-Luther-Universität
Halle-Wittenberg, Institut für Medizinische Soziologie, Halle (Saale),
Deutschland
| | - S Weise
- Medizinische Fakultät der Martin-Luther-Universität
Halle-Wittenberg, Institut für Allgemeinmedizin, Halle (Saale),
Deutschland
| | - A Fink
- Medizinische Fakultät der Martin-Luther-Universität
Halle-Wittenberg, Institut für Medizinische Soziologie, Halle (Saale),
Deutschland
| | - T Frese
- Medizinische Fakultät der Martin-Luther-Universität
Halle-Wittenberg, Institut für Allgemeinmedizin, Halle (Saale),
Deutschland
| | - A Knöchelmann
- Medizinische Fakultät der Martin-Luther-Universität
Halle-Wittenberg, Institut für Medizinische Soziologie, Halle (Saale),
Deutschland
| |
Collapse
|
6
|
Hoffmann L, Bernard M, Gebhard B, Völlm C, Fink A, Richter M. PartJu: Ergebnisse zur Konzeptualisierung von sozialer Partizipation
von Jugendlichen mit und ohne körperlich-motorischen
Beeinträchtigungen und/oder chronischen
Erkrankungen. Das Gesundheitswesen 2022. [DOI: 10.1055/s-0042-1753785] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- L Hoffmann
- Martin-Luther Universität Halle-Wittenberg, Institut
für Medizinische Soziologie, Halle, Deutschland
| | - M Bernard
- Martin-Luther Universität Halle-Wittenberg, Institut
für Medizinische Soziologie, Halle, Deutschland
| | - B Gebhard
- Fachhochschule Südwestfalen, Fachbereich Bildungs- und
Gesellschaftswissenschaften, Soest, Deutschland
| | - C Völlm
- Fachhochschule Südwestfalen, Fachbereich Bildungs- und
Gesellschaftswissenschaften, Soest, Deutschland
| | - A Fink
- Kreis Groß-Gerau, Abteilung für Gesundheit und
Verbraucherschutz, Groß-Gerau, Deutschland
| | - M Richter
- Technische Universität München, Department of Sport and
Health Sciences, München, Deutschland
| |
Collapse
|
7
|
Leinert E, Fink A, Veselinovic K, De Waal A, Wang-Gohrke S, Janni W, Fink V. Erstdiagnose einer heterozygoten TP53 Keimbahnmutation bei einer
28-jährigen Patientin mit triple-negativem Mammakarzinom und
kontralateralem DCIS. Geburtshilfe Frauenheilkd 2022. [DOI: 10.1055/s-0042-1749031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
8
|
Goss C, Cromwell E, Ostrenga J, Fink A, Morgan W. 29: Utilizing latent class mixed models to identify patterns in lung function in children with CF. J Cyst Fibros 2021. [DOI: 10.1016/s1569-1993(21)01454-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
9
|
Yamoah K, Lee K, Alba P, Awasthi S, Perez C, Gao A, Anglin T, Robison B, Duvall S, Katsoulakis E, Wong Y, Markt S, Rose B, Burri R, Wang C, Aboiralor O, Fink A, Nickols N, Lynch J, Garraway I. Defining Racial Disparities Across the Prostate Cancer Disease Continuum in an Equal Access-to-Care Setting Within the Nation's Largest Healthcare Network. Int J Radiat Oncol Biol Phys 2021. [DOI: 10.1016/j.ijrobp.2021.07.306] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
10
|
Feitz R, Stip D, van der Oest M, Souer S, Hovius S, Selles R, Blomme R, Sluijter B, van der Avoort D, Kroeze A, Smit J, Debeij J, Walbeehm E, van Couwelaar G, Vermeulen GM, de Schipper J, Temming J, van Uchelen J, de Boer H, de Haas K, Harmsen K, Zöphel O, Koch R, Moojen T, Smit X, van Huis R, Pennehouat P, Schoneveld K, van Kooij Y, Wouters R, Veltkamp J, Fink A, de Ridder W, Poelstra R, Slijper H, Selles R, Tsehaie J, Janssen M, Sun P, Schrier V, Hoogendam L, Dekker J, Jansen-Landheer M, Stege MT. Prognostic Factors in Open Triangular Fibrocartilage Complex (TFCC) Repair. Journal of Hand Surgery Global Online 2021; 3:176-181. [PMID: 35415558 PMCID: PMC8991529 DOI: 10.1016/j.jhsg.2021.05.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/10/2021] [Accepted: 05/08/2021] [Indexed: 11/17/2022] Open
Abstract
Purpose Patients with triangular fibrocartilage complex (TFCC) injury report ulnar-sided wrist pain and impaired function. Open TFCC repair aims to improve the condition of these patients. Patients have shown reduction in pain and improvement in function at 12 months after surgery; however, results are highly variable. The purpose of this study was to relate patient (eg, age and sex), disease (eg, trauma history and arthroscopic findings), and surgery factors (type of bone anchor) associated with pain and functional outcomes at 12 months after surgery. Methods This study included patients who underwent an open TFCC repair between December 2011 and December 2018 in various Xpert Clinics in the Netherlands. All patients were asked to complete Patient-Rated Wrist Evaluation (PRWE) questionnaires at baseline as well as at 12 months after surgery. Patient, disease, and surgery factors were extracted from digital patient records. All factors were analyzed by performing a multivariable hierarchical linear regression. Results We included 274 patients who had received open TFCC repair and completed PRWE questionnaires. Every extra month of symptoms before surgery was correlated with an increase of 0.14 points on the PRWE total score at 12 months after surgery. In addition, an increase of 0.28 points in the PRWE total score at 12 months was seen per extra point of PRWE total score at baseline. Conclusions Increased preoperative pain, less preoperative function, and a longer duration of complaints are factors that were associated with more pain and less function at 12 months after open surgery for TFCC. This study arms surgeons with data to predict outcomes for patients undergoing open TFCC repair. Type of study/level of evidence Prognostic II.
Collapse
|
11
|
Al‐Sawaf O, Zhang C, Robrecht S, Tandon M, Panchal A, Fink A, Tausch E, Ritgen M, Kreuzer K, Kim S, Wendtner C, Eichhorst B, Stilgenbauer S, Jiang Y, Hallek M, Fischer K. VENETOCLAX‐OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 4‐YEAR FOLLOW‐UP ANALYSIS OF THE RANDOMIZED CLL14 STUDY. Hematol Oncol 2021. [DOI: 10.1002/hon.49_2880] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- O. Al‐Sawaf
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - C. Zhang
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - S. Robrecht
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - M. Tandon
- Roche Products Limited Welwyn Garden City UK
| | - A. Panchal
- Roche Products Limited Welwyn Garden City UK
| | - A.‐M. Fink
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - E. Tausch
- University Hospital Ulm Department III of Internal Medicine Ulm Germany
| | - M. Ritgen
- University of Schleswig‐Holstein Department II of Internal Medicine Kiel Germany
| | - K.‐A. Kreuzer
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | | | - C. Wendtner
- Klinikum Schwabing Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine Munich Germany
| | - B. Eichhorst
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - S. Stilgenbauer
- University Hospital Ulm Department III of Internal Medicine Ulm Germany
| | | | - M. Hallek
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - K. Fischer
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| |
Collapse
|
12
|
Al‐Sawaf O, Robrecht S, Stumpf J, Fink A, Ritgen M, Johansson P, Tausch E, Hoechstetter M, Staber P, Jäger U, Niemann CU, Pallasch C, Kreuzer K, Stilgenbauer S, Fischer K, Wendtner C, Hallek M, Eichhorst B. THE CLL‐RT1 TRIAL: A MULTICENTER PHASE‐2 TRIAL OF ZANUBRUTINIB, A BTK INHIBITOR, PLUS TISLELIZUMAB, A PD‐1 INHIBITOR, FOR PATIENTS WITH RICHTER TRANSFORMATION. Hematol Oncol 2021. [DOI: 10.1002/hon.161_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- O. Al‐Sawaf
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - S. Robrecht
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - J. Stumpf
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - A.‐M. Fink
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - M. Ritgen
- University of Schleswig‐Holstein Department II of Internal Medicine Kiel Germany
| | - P. Johansson
- University Hospital Essen Clinic for Hematology Essen Germany
| | - E. Tausch
- University Hospital Ulm Department III of Internal Medicine Ulm Germany
| | - M. Hoechstetter
- Klinikum Schwabing Department of Hematology Oncology Immunology Palliative Care Infectious Diseases and Tropical Medicine Munich Germany
| | - P. Staber
- Medical University of Vienna Department of Medicine I Division of Hematology & Hemostaseology Vienna Austria
| | - U. Jäger
- Medical University of Vienna Department of Medicine I Division of Hematology & Hemostaseology Vienna Austria
| | - C. U. Niemann
- Department of Haematology Rigshospitalet and Department of Clinical Medicine University of Copenhagen, Denmark Copenhagen Denmark
| | - C. Pallasch
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - K.‐A. Kreuzer
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - S. Stilgenbauer
- University Hospital Ulm Department III of Internal Medicine Ulm Germany
| | - K. Fischer
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - C. Wendtner
- Klinikum Schwabing Department of Hematology Oncology Immunology Palliative Care Infectious Diseases and Tropical Medicine Munich Germany
| | - M. Hallek
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| | - B. Eichhorst
- University Hospital of Cologne Department I of Internal Medicine Cologne Germany
| |
Collapse
|
13
|
Kohl Schwartz AS, Calzaferri I, Roumet M, Limacher A, Fink A, Wueest A, Weidlinger S, Mitter VR, Leeners B, Von Wolff M. Follicular flushing leads to higher oocyte yield in monofollicular IVF: a randomized controlled trial. Hum Reprod 2021; 35:2253-2261. [PMID: 32856073 PMCID: PMC7518713 DOI: 10.1093/humrep/deaa165] [Citation(s) in RCA: 22] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2020] [Revised: 06/04/2020] [Indexed: 11/22/2022] Open
Abstract
STUDY QUESTION Does follicular flushing increase the number of mature oocytes in monofollicular IVF? SUMMARY ANSWER Follicular flushing increases the number of mature oocytes in monofollicular IVF. WHAT IS KNOWN ALREADY Flushing increases neither the oocyte yield nor the pregnancy rate in polyfollicular IVF or in poor responder patients. In monofollicular IVF, the effect of flushing has so far been addressed by two studies: (i) a prospective study with minimal stimulation IVF demonstrated an increased oocyte yield, and (ii) a retrospective study with natural cycle (NC)-IVF showed an increased oocyte yield and an increased transfer rate. STUDY DESIGN, SIZE, DURATION Randomized controlled trial including 164 women who were randomized for either aspiration with or without flushing from 2016 to 2019. PARTICIPANTS/MATERIALS, SETTING, METHODS Infertile women 18–42 years of age with an indication for IVF treatment at a university-based infertility unit. Women undergoing monofollicular IVF were randomized to either follicular aspiration only or follicular aspiration directly followed by five follicular flushes at a 1:1 ratio. The intervention was done without anaesthesia, using a gauge 19 single-lumen needle. Flushing volume was calculated (sphere formula) based on the size of the follicle. MAIN RESULTS AND THE ROLE OF CHANCE A total of 164 women were included; 81 were allocated to ‘aspiration only’ and 83 to additional ‘flushing’. Primary analysis was based on the intention-to-treat: oocyte yield, defined as the collected mature oocyte rate, was higher (n = 64/83, 77.1%) in the flushing group compared to the aspiration only group (n = 48/81, 59.3%, adjusted risk difference (RD): 18.2% (95% CI 3.9–31.7%), P-value = 0.02). In the flushing group, most oocytes were retrieved within the first three flushes (63/83, 75.8%). Fertilization rate was higher in the flushing group (n = 53/83, 63.9% vs n = 38/81, 46.9%; adjusted RD: 16.8% (96% CI 1.5–31.4%), P = 0.045). Transfer rate was also higher in the flushing group (n = 52/83, 62.7% vs n = 38/81, 46.9%; RD: 15.71 (95% CI 0.3–30.3%)), but the difference was not significant (P = 0.06). The clinical pregnancy rate n = 9/83 versus n = 9/81 (RD: −0.3% (95% CI −9.9% to 9.5%)) and live birth rate n = 7/83 versus n = 8/81 (RD: −1.5% (95% CI −10.4% to 7.1%)) were not significantly different between the flushing and the aspiration group. The median duration of the intervention was significantly longer with flushing (2.38 min; quartiles 2.0, 2.7) versus aspiration only (0.43 min; quartiles 0.3, 0.5) (P < 0.01). There was no significant difference in the mean (±SD) visual analogue scales pain score between the follicular flushing (3.4 ± 1.8) and the aspiration group (3.1 ± 1.89). LIMITATIONS, REASONS FOR CAUTION Blinding of the procedure was not possible. WIDER IMPLICATIONS OF THE FINDINGS Our study proved that flushing of single follicles in NC-IVF increases the oocyte yield. In contrast to polyfollicular IVF flushing seems to be beneficial in a monofollicular setting if the technique used in our study (single-lumen needle, 5 flushings with flushing volume adaptation) is applied. STUDY FUNDING/COMPETING INTEREST(S) The study was funded by the financial sources of the division and in part by a research grant provided by NMS Biomedical SA, Switzerland. The company did not have any roles in design or conduct of the study or in the preparation of the manuscript. The authors have no other conflicts of interest. TRIAL REGISTRATION NUMBER Clinicaltrials.gov NCT 02641808. TRIAL REGISTRATION DATE 29 December 2015 DATE OF FIRST PATIENT’S ENROLMENT 22 August 2016
Collapse
Affiliation(s)
- A S Kohl Schwartz
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital, University of Bern, Inselspital, 3010 Bern, Switzerland
| | - I Calzaferri
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital, University of Bern, Inselspital, 3010 Bern, Switzerland
| | - M Roumet
- CTU Bern, University of Bern, Bern, Switzerland
| | - A Limacher
- CTU Bern, University of Bern, Bern, Switzerland
| | - A Fink
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital, University of Bern, Inselspital, 3010 Bern, Switzerland
| | - A Wueest
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital, University of Bern, Inselspital, 3010 Bern, Switzerland
| | - S Weidlinger
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital, University of Bern, Inselspital, 3010 Bern, Switzerland
| | - V R Mitter
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital, University of Bern, Inselspital, 3010 Bern, Switzerland
| | - B Leeners
- Department of Reproductive Endocrinology, University Hospital Zurich, Zurich, Switzerland
| | - M Von Wolff
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital, University of Bern, Inselspital, 3010 Bern, Switzerland
| |
Collapse
|
14
|
Hiebler-Ragger M, Perchtold-Stefan CM, Unterrainer HF, Fuchshuber J, Koschutnig K, Nausner L, Kapfhammer HP, Papousek I, Weiss EM, Fink A. Lower cognitive reappraisal capacity is related to impairments in attachment and personality structure in poly-drug use: an fMRI study. Brain Imaging Behav 2021; 15:2187-2198. [PMID: 33222012 PMCID: PMC8413209 DOI: 10.1007/s11682-020-00414-3] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/30/2020] [Indexed: 01/19/2023]
Abstract
Insecure attachment, impaired personality structure and impaired emotion regulation figure prominently in substance use disorders. While negative emotions can trigger drug-use and relapse, cognitive reappraisal may reduce emotional strain by promoting changes in perspective. In the present study, we explored behavioral and neural correlates of cognitive reappraisal in poly-drug use disorder by testing individuals' capability to generate cognitive reappraisals for aversive events (Reappraisal Inventiveness Test). 18 inpatients with poly-drug use disorder and 16 controls completed the Adult Attachment Scale, the Emotion Regulation Questionnaire, the Brief Symptom Inventory, the Wonderlic Personnel Test, and the Operationalized Psychodynamic Diagnosis Structure Questionnaire, as well as two versions of the Reappraisal Inventiveness Test (during fMRI and outside the lab). Compared to controls, polydrug inpatients reported impaired personality structure, attachment and emotion regulation abilities. In the Reappraisal Inventiveness Test, poly-drug inpatients were less flexible and fluent in generating reappraisals for anger-eliciting situations. Corresponding to previous brain imaging evidence, cognitive reappraisal efforts of both groups were reflected in activation of left frontal regions, particularly left superior and middle frontal gyri and left supplemental motor areas. However, no group differences in neural activation patterns emerged. This suggests that despite cognitive reappraisal impairments on a behavioral level, neural reflections of these deficits in poly-drug use disorder might be more complex.
Collapse
Affiliation(s)
- M. Hiebler-Ragger
- University Clinic of Psychiatry and Psychotherapeutic Medicine, Medical University, Auenbruggerplatz 31, 8036, Graz, Austria ,Center for Integrative Addiction Research (CIAR), Grüner Kreis Society, Simmeringer Hauptstraße 101, 1110 Vienna, Austria
| | | | - H. F. Unterrainer
- University Clinic of Psychiatry and Psychotherapeutic Medicine, Medical University, Auenbruggerplatz 31, 8036, Graz, Austria ,Center for Integrative Addiction Research (CIAR), Grüner Kreis Society, Simmeringer Hauptstraße 101, 1110 Vienna, Austria ,Department of Religious Studies, University of Vienna, Schenkenstraße 8-10, 1010 Vienna, Austria
| | - J. Fuchshuber
- University Clinic of Psychiatry and Psychotherapeutic Medicine, Medical University, Auenbruggerplatz 31, 8036, Graz, Austria ,Center for Integrative Addiction Research (CIAR), Grüner Kreis Society, Simmeringer Hauptstraße 101, 1110 Vienna, Austria
| | - K. Koschutnig
- Institute of Psychology, University of Graz, Universitätsplatz 2, 8010 Graz, Austria
| | - L. Nausner
- Fachsektion Integrative Gestalttherapie, Österreichischer Arbeitskreis für Gruppentherapie und Gruppendynamik, Lenaugasse 3, 1080 Vienna, Austria
| | - H. P. Kapfhammer
- University Clinic of Psychiatry and Psychotherapeutic Medicine, Medical University, Auenbruggerplatz 31, 8036, Graz, Austria ,Department of Medical Psychology and Psychotherapy, Medical University of Graz, Auenbruggerplatz 43, 8036, Graz, Austria
| | - I. Papousek
- Institute of Psychology, University of Graz, Universitätsplatz 2, 8010 Graz, Austria
| | - E. M. Weiss
- Institute of Psychology, University of Innsbruck, Innrain 52f, 6020 Innsbruck, Austria
| | - A. Fink
- Institute of Psychology, University of Graz, Universitätsplatz 2, 8010 Graz, Austria
| |
Collapse
|
15
|
Awasthi S, Berglund A, Rounbehler R, Gerke T, Serna A, Abraham J, Fink A, DeNicola G, Dhillon J, Park J, Yamoah K. Comparative Genomics to Uncover Distinct Immune-oncologic Pathways in African American Men with Prostate Cancer. Int J Radiat Oncol Biol Phys 2020. [DOI: 10.1016/j.ijrobp.2020.07.838] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
16
|
Heser K, Fink A, Reinke C, Wagner M, Doblhammer G. The temporal association between incident late-life depression and incident dementia. Acta Psychiatr Scand 2020; 142:402-412. [PMID: 32712956 DOI: 10.1111/acps.13220] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 07/20/2020] [Indexed: 12/22/2022]
Abstract
OBJECTIVE There is an established association between depression and subsequent dementia. The present study examined temporal associations between incident late-life depression and subsequent dementia, also considering age and sex. METHODS We used longitudinal health claims data from the largest German health insurance provider ('Allgemeine Ortskrankenkasse') considering up to 9 follow-up years in piecewise exponential models. ICD-10 codes were used to define incident depression and dementia in individuals ≥65 years (n = 97 110). RESULTS Incident depression was associated with a higher risk of subsequent dementia (incidence rate ratios (IRR) adjusted for age and sex: IRR = 1.58, 95% CI = 1.51-1.64). The strongest association was found for the shortest interval of 1 quarter (IRR = 2.04, 95% CI = 1.88-2.21), with significant associations up to an interval of roughly 3 years. The association was more pronounced and lasted for more quarters in the younger portion of this study group (ages from 65-74: IRR = 2.00, 95% CI = 1.83-2.18; 75-84: IRR = 1.64, 95% CI = 1.55-1.73; ≥85: IRR = 1.19, 95% CI = 1.08-1.31). It was stronger among men than women (men: IRR = 1.98, 95% CI = 1.84-2.14; women: IRR = 1.44, 95% CI = 1.37-1.51) with no sex-specific temporal association. CONCLUSION This large claims data study confirmed that incident late-life depression is associated with a higher risk of dementia within the 3 years following diagnosis. Hence, incident late-life depression should prompt further cognitive examinations and referrals to specialists. This might apply especially to younger seniors and men.
Collapse
Affiliation(s)
- K Heser
- Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, North Rhine-Westphalia, 53127, Germany
| | - A Fink
- German Center for Neurodegenerative Diseases (DZNE), Bonn, North Rhine-Westphalia, Germany
| | - C Reinke
- University of Rostock, Rostock, Mecklenburg-West Pomerania, Germany
| | - M Wagner
- Department of Neurodegenerative Diseases and Geriatric Psychiatry, University Hospital Bonn, Bonn, North Rhine-Westphalia, 53127, Germany.,German Center for Neurodegenerative Diseases (DZNE), Bonn, North Rhine-Westphalia, Germany
| | - G Doblhammer
- German Center for Neurodegenerative Diseases (DZNE), Bonn, North Rhine-Westphalia, Germany.,University of Rostock, Rostock, Mecklenburg-West Pomerania, Germany
| |
Collapse
|
17
|
Fink A, Braun T, Heitmeir B, Bartholomä S, De Gregorio A, Janni W, De Gregorio N. 12-jähriges Mädchen mit FIGO IIIa Ovarialkarzinom – Eine extrem seltene Tumorerkrankung. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1718262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
| | | | | | - S Bartholomä
- Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm
| | | | | | | |
Collapse
|
18
|
Uhde M, Smoll S, Fink A, de Gregorio A, Janni W, Lewerenz J, Huober J. Paraneoplastische Cerebellitis bei okkultem, axillär metastasiertem Her2-positivem Mammakarzinom – Case-Report einer 59jährigen Patientin. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1718338] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
19
|
Braun T, Baumann L, Rack B, Fritz J, Fink A, Koretz K, Fink V, Huober J, Janni W, De Gregorio A, De Gregorio N. Myofibroblastom der Brust – eine differentialdiagnostische Herausforderung. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1718253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- T Braun
- Universitätsklinikum Ulm, Klinik Für Frauenheilkunde und Geburtshilfe
| | - L Baumann
- Universitätsklinikum Ulm, Institut für Pathologie
| | - B Rack
- Universitätsklinikum Ulm, Klinik Für Frauenheilkunde und Geburtshilfe
| | - J Fritz
- Universitätsklinikum Ulm, Klinik Für Frauenheilkunde und Geburtshilfe
| | - A Fink
- Universitätsklinikum Ulm, Klinik Für Frauenheilkunde und Geburtshilfe
| | - K Koretz
- Universitätsklinikum Ulm, Institut für Pathologie
| | - V Fink
- Universitätsklinikum Ulm, Klinik Für Frauenheilkunde und Geburtshilfe
| | - J Huober
- Universitätsklinikum Ulm, Klinik Für Frauenheilkunde und Geburtshilfe
| | - W Janni
- Universitätsklinikum Ulm, Klinik Für Frauenheilkunde und Geburtshilfe
| | - A De Gregorio
- Universitätsklinikum Ulm, Klinik Für Frauenheilkunde und Geburtshilfe
| | - N De Gregorio
- Universitätsklinikum Ulm, Klinik Für Frauenheilkunde und Geburtshilfe
| |
Collapse
|
20
|
Kohl Schwartz AS, Burkard S, Mitter VR, Leichtle AB, Fink A, Von Wolff M. Short-term application of ibuprofen before ovulation. Facts Views Vis Obgyn 2020; 12:179-184. [PMID: 33123693 PMCID: PMC7580263] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Abstract
AIM OF THE STUDY The aim was to analyse if ibuprofen, as a non-selective cyclooxygenase (COX) inhibitor, has any negative effect on oocyte competence and embryo quality. COX- inhibitors are popular over-the-counter analgesics. Whereas selective COX inhibitors have been shown to impair female fertility, data on non-selective COX inhibitors are poor. Hence, they have not been recommended for women trying to conceive. METHODS This is an observational study comparing ibuprofen exposed and unexposed women from 18 to 42 years of age, using the model of natural cycle in vitro fertilisation (IVF) to determine oocyte and embryo quality. Follicular growth was monitored and if the follicle was mature (≥ 15mm size and estimated oestradiol level of ≥ 800pmol/l), ovulation was triggered. Women with luteinising hormone (LH) surge received 400mg ibuprofen every 8 hours to postpone ovulation, whereas women without LH surge received none (controls). Oocyte retrieval rate, oocyte maturity, fertilization rate, embryo development and embryo quality as well as implantation rate were analysed. RESULTS Of the 111 women included, 63 received ibuprofen, and 48 did not. Rates of mature oocytes and implantation rate did not differ. Logistic regression showed no significant association of ibuprofen intake, LH- level or reason for infertility on embryo quality. CONCLUSION Based on our results, we suggest that, particularly within natural cycle IVF, ibuprofen does no harm around ovulation as analgesic treatment.
Collapse
Affiliation(s)
- AS Kohl Schwartz
- University Women’s Hospital, Division of Gynecological Endocrinology and Reproductive Medicine, Inselspital, Bern University Hospital, Bern, Switzerland
| | - S Burkard
- University Women’s Hospital, Division of Gynecological Endocrinology and Reproductive Medicine, Inselspital, Bern University Hospital, Bern, Switzerland
| | - VR Mitter
- University Women’s Hospital, Division of Gynecological Endocrinology and Reproductive Medicine, Inselspital, Bern University Hospital, Bern, Switzerland
| | - AB Leichtle
- Department of Clinical Chemistry, Inselspital, Bern University Hospital, Bern, Switzerland
| | - A Fink
- University Women’s Hospital, Division of Gynecological Endocrinology and Reproductive Medicine, Inselspital, Bern University Hospital, Bern, Switzerland
| | - M Von Wolff
- University Women’s Hospital, Division of Gynecological Endocrinology and Reproductive Medicine, Inselspital, Bern University Hospital, Bern, Switzerland
| |
Collapse
|
21
|
Wörrlein S, Uhde M, Fink A, deGregorio A, Janni W, Lewerenz J, Huober J. Case-Report einer 59jährigen Patientin mit okkultem, axillär metastasiertem Her2-positivem Mammakarzinom – aufgefallen durch eine paraneoplastische Cerebellitis. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1713988] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
| | - M Uhde
- Universitätsfrauenklinik Ulm
| | - A Fink
- Universitätsfrauenklinik Ulm
| | | | - W Janni
- Universitätsfrauenklinik Ulm
| | - J Lewerenz
- Universitätsklinik Ulm, Klinik für Neurologie
| | | |
Collapse
|
22
|
Fink A, Braun T, Heitmeir B, Bartholomä S, deGregorio A, Janni W, deGregorio N. Hyperkalzämisches Ovarialkarzinom bei einem 12-jähriges Mädchen – Eine Rarität. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1713974] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Affiliation(s)
- A Fink
- Universitätsfrauenklinik Ulm
| | - T Braun
- Universitätsfrauenklinik Ulm
| | | | - S Bartholomä
- Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Ulm
| | | | - W Janni
- Universitätsfrauenklinik Ulm
| | | |
Collapse
|
23
|
Fuchshuber J, Unterrainer HF, Hiebler-Ragger M, Koschutnig K, Papousek I, Weiss EM, Fink A. Pinpointing Neural Correlates of Attachment in Poly-Drug Use: A Diffusion Tensor Imaging Study. Front Neurosci 2020; 14:596. [PMID: 32595448 PMCID: PMC7300178 DOI: 10.3389/fnins.2020.00596] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2019] [Accepted: 05/15/2020] [Indexed: 01/03/2023] Open
Abstract
An increasing amount of evidence indicates the significance of attachment in the etiology of poly-drug use disorder (PUD). The aim of this study was to investigate associations between PUD and adult attachment in particular, with a focus on white matter (WM) fiber tract integrity. For this purpose, we selected several regions-of-interest based on previous findings which were examined for their role in PUD and estimated whole-brain associations between adult attachment and WM integrity. A total sample of 144 right-handed males were investigated (Age: M = 27; SD = 4.66). This included a group of patients diagnosed with PUD (n = 70) and a group of healthy controls (HC; n = 74). The Adult Attachment Scales (AAS) was applied to assess attachment attitudes in participants. Diffusion Tensor Imaging was used to investigate differences in WM integrity. The findings suggest substantially less attachment security in PUD patients compared to HC. Furthermore, PUD patients exhibited reduced integrity in WM fiber tracts, most pronounced in the bilateral corticospinal tract, the fronto-occipital fasciculus, and the right inferior longitudinal fasciculus. However, these results were not controlled for comorbid depressiveness. With regard to associations between adult attachment and WM integrity, the results for PUD patients indicate a negative relationship between "Comfort with Closeness" and the structural integrity of a cluster comprising parts of the right anterior thalamic radiation, the inferior fronto-occipital fasciculus and the uncinate fasciculus. Despite being limited by the cross-sectional design of this study, the results emphasize the significance of attachment in PUD etiology, both at a behavioral and a neurological level. Largely in line with previous research, the findings revealed tentative links between adult attachment and WM fiber tracts related to cognitive and affective functions in PUD patients.
Collapse
Affiliation(s)
- J. Fuchshuber
- Center for Integrative Addiction Research (CIAR), Grüner Kreis Society, Vienna, Austria
- University Clinic for Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria
| | - H. F. Unterrainer
- Center for Integrative Addiction Research (CIAR), Grüner Kreis Society, Vienna, Austria
- University Clinic for Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria
- Department of Religious Studies, University of Vienna, Vienna, Austria
| | - M. Hiebler-Ragger
- Center for Integrative Addiction Research (CIAR), Grüner Kreis Society, Vienna, Austria
- University Clinic for Psychiatry and Psychotherapeutic Medicine, Medical University of Graz, Graz, Austria
| | - K. Koschutnig
- Institute of Psychology, University of Graz, Graz, Austria
| | - I. Papousek
- Institute of Psychology, University of Graz, Graz, Austria
| | - E. M. Weiss
- Institute of Psychology, University of Innsbruck, Innsbruck, Austria
| | - A. Fink
- Institute of Psychology, University of Graz, Graz, Austria
| |
Collapse
|
24
|
Mithani S, Yun S, Pattinson C, Kim H, Guedes V, Fink A, Weljie A, Gehrman P, Gill J. 0021 RNA Sequencing Reveals Transcriptomic Changes in Individuals with Insomnia. Sleep 2020. [DOI: 10.1093/sleep/zsaa056.020] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
Abstract
Introduction
Insomnia affects 10–20% of the US population and is associated with negative health and psychosocial sequelae. Despite the public health impact of insomnia little is known about its underlying molecular mechanisms. The purpose of this study is to examine differentially expressed genes in 15 patients with chronic insomnia and age- and sex-matched good sleepers (n=15).
Methods
We performed total RNA-seq on 30 whole blood samples collected at 09:00 at 150 bp paired-ends on the Illumina NovaSeq-6000 platform. Alignment was performed using the STAR version 2.7.2a software on the human reference genome (GRCh38). Differential gene expression analysis was performed using DESeq2 version 1.24.0. Pathway analysis was performed using IPA, release 2019-08-30.
Results
An average of 86.7 million paired end reads per sample were sequenced. We found that 289 genes were differentially expressed in insomnia patients with a log fold change (LFC) ±0.50 and had a FDR p-value < 0.05. Top dysregulated genes include CSMD1 (L2FC=-2.78; p=1.35E-06), DUX4L9 (L2FC=3.40; p=2.81E-06) and GRM4 (L2FC=2.45; p=4.50E-05). Among the functionally relevant genes, CSMD encodes a complement control protein that is known to participate in the complement activation and inflammation in the developing central nervous system. UTS2 (L2FC=1.778; p=8.94E-06) is involved in regulation of orexin A and B activity and rapid eye movement during sleep. Ingenuity Pathway Analysis revealed 3 associated networks: Hematological, Hereditary Disorder, Organismal Injury and Abnormalities (score: 46), Developmental, Hereditary Disorder, Metabolic Disease (score: 43), and Cell Cycle, Cell mediated Immune Response, Cellular Development (score: 43).
Conclusion
Overall, our study revealed dysregulated genes in individuals who suffer from insomnia. Notably, dysregulation of these functionally relevant genes could impair functional brain connectivity and synaptic function. Further investigation of these biological pathways will be useful to elucidate the pathogenesis of insomnia and identify novel biomarkers or drug targets for developing improved diagnostics and therapeutics.
Support
National Institutes of Nursing Research, Graduate Partnership Program
Collapse
Affiliation(s)
- S Mithani
- National Institutes of Health, Bethesda, MD
| | - S Yun
- Yotta Biomed, LLC., Bethesda, MD
| | | | - H Kim
- National Institutes of Health, Bethesda, MD
| | - V Guedes
- National Institutes of Health, Bethesda, MD
| | - A Fink
- University of Illinois at Chicago, Chicago, IL
| | - A Weljie
- University of Pennsylvania, Department of Psychiatry, Philadelphia, PA
| | - P Gehrman
- University of Pennsylvania, Department of Pharmacology, Philadelphia, PA
| | - J Gill
- National Institutes of Health, Bethesda, MD
| |
Collapse
|
25
|
Henn A, He Y, Darou S, Murray K, Fink A, Cundell T, Yerden R. Aseptic conditions for antibiotic-free cell processing for cellular therapies. Cytotherapy 2020. [DOI: 10.1016/j.jcyt.2020.03.296] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
26
|
Wouters RM, Slijper HP, Esteban Lopez L, Hovius SE, Selles RW, Blomme R, Sluijter B, van der Avoort D, Kroeze A, Smit J, Debeij J, Walbeehm E, van Couwelaar G, Vermeulen G, de Schipper J, Temming J, van Uchelen J, de Boer H, de Haas K, Zöphel O, Feitz R, Souer J, Hovius S, Moojen T, Smit X, van Huis R, Pennehouat P, Schoneveld K, van Kooij Y, Wouters R, Zagt P, van Ewijk F, Moussault F, Veltkamp J, Fink A, de Ridder W, Slijper H, Selles R, Porsius J, Spekreijse K, Zhou C, Tsehaie J, Poelstra R, Janssen M, van der Oest M, Evers S, Sun P, Schrier V, Dekker J, Jansen-Landheer M, ter Stege M. Beneficial Effects of Nonsurgical Treatment for Symptomatic Thumb Carpometacarpal Instability in Clinical Practice: A Cohort Study. Arch Phys Med Rehabil 2020; 101:434-441. [DOI: 10.1016/j.apmr.2019.08.485] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2019] [Revised: 07/23/2019] [Accepted: 08/31/2019] [Indexed: 11/24/2022]
|
27
|
Tausch E, Bahlo J, Robrecht S, Schneider C, Bloehdorn J, Schrell S, Galler C, Al-Sawaf O, Fink A, Eichhorst B, Kreuzer K, Tandon M, Humphrey K, Jiang Y, Schary W, Porro Lurà M, Döhner H, Fischer K, Hallek M, Stilgenbauer S. GENETIC MARKERS AND OUTCOME IN THE CLL14 TRIAL OF THE GCLLSG COMPARING FRONT LINE OBINUTUZUMAB PLUS CHLORABMUCIL OR VENETOCLAX IN PATIENTS WITH COMORBIDITY Best abstract submitted by a young investigator / travel grant recipient. Hematol Oncol 2019. [DOI: 10.1002/hon.53_2629] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Affiliation(s)
- E. Tausch
- Department of Internal Medicine 3; Ulm University; Ulm Germany
| | - J. Bahlo
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital Cologne; Cologne Germany
| | - S. Robrecht
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital Cologne; Cologne Germany
| | - C. Schneider
- Department of Internal Medicine 3; Ulm University; Ulm Germany
| | - J. Bloehdorn
- Department of Internal Medicine 3; Ulm University; Ulm Germany
| | - S. Schrell
- Department of Internal Medicine 3; Ulm University; Ulm Germany
| | - C. Galler
- Department of Internal Medicine 3; Ulm University; Ulm Germany
| | - O. Al-Sawaf
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital Cologne; Cologne Germany
| | - A. Fink
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital Cologne; Cologne Germany
| | - B. Eichhorst
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital Cologne; Cologne Germany
| | - K. Kreuzer
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital Cologne; Cologne Germany
| | - M. Tandon
- Clinical Development Oncology; Roche; Welwyn Garden City United Kingdom
| | - K. Humphrey
- Clinical Development Oncology; Roche; Welwyn Garden City United Kingdom
| | - Y. Jiang
- Oncology Biomarker Development; Genentech; South San Francisco United States
| | - W. Schary
- Oncology; Abbvie Inc; North Chicago United States
| | - M. Porro Lurà
- Pharmaceuticals Division; F. Hoffmann - La Roche Ltd; Basel Switzerland
| | - H. Döhner
- Department of Internal Medicine 3; Ulm University; Ulm Germany
| | - K. Fischer
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital Cologne; Cologne Germany
| | - M. Hallek
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital Cologne; Cologne Germany
| | - S. Stilgenbauer
- Department of Internal Medicine 3; Ulm University; Ulm Germany
| |
Collapse
|
28
|
Fischer K, Porro Lurà M, Al-Sawaf O, Bahlo J, Fink A, Tandon M, Dixon M, Robrecht S, Warburton S, Humphrey K, Samoylova O, Liberati A, Pinilla-Ibarz J, Opat S, Sivcheva L, Le Dû K, Fogliatto L, Utoft Niemann C, Weinkove R, Robinson S, Kipps T, Boettcher S, Tausch E, Schary W, Eichhorst B, Wendtner C, Langerak A, Kreuzer K, Goede V, Stilgenbauer S, Mobasher M, Ritgen M, Hallek M. FIXED-DURATION VENETOCLAX PLUS OBINUTUZUMAB IMPROVES PFS AND MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL AND COMORBIDITIES. Hematol Oncol 2019. [DOI: 10.1002/hon.52_2629] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/10/2022]
Affiliation(s)
- K. Fischer
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - M. Porro Lurà
- Pharmaceuticals Division; PDGo, F. Hoffmann-La Roche Ltd; Basel Switzerland
| | - O. Al-Sawaf
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - J. Bahlo
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - A. Fink
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - M. Tandon
- Clinical Development Oncology; Roche Products Limited; Welwyn Garden City United Kingdom
| | - M. Dixon
- Biostatistics; Roche Products Limited; Welwyn Garden City United Kingdom
| | - S. Robrecht
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - S. Warburton
- Product Development - Oncology; Roche Products Limited; Welwyn Garden City United Kingdom
| | - K. Humphrey
- Clinical Development Oncology; Roche Products Limited; Welwyn Garden City United Kingdom
| | - O. Samoylova
- Hematology Department; Regional Clinical Hospital N.A. Semashko; Nizhny Novgorod Russian Federation
| | - A.M. Liberati
- Division of Onco-Hematology; Santa Maria Terni Hospital, University of Perugia; Perugia Italy
| | - J. Pinilla-Ibarz
- Department of Malignant Hematology; H. Lee Moffitt Cancer Center & Research Institute; Tampa FL United States
| | - S. Opat
- Haematology Department; School of Clinical Sciences at Monash Health; Monash University Victoria Australia
| | - L. Sivcheva
- First Internal Department; MHAT Hristo Botev; AD, Vratsa Bulgaria
| | - K. Le Dû
- Hematology Department; Clinique Victor Hugo; Le Mans France
| | - L.M. Fogliatto
- Department of Hematology; Hospital de Clínicas de Porto Alegre; Porto Alegre Brazil
| | - C. Utoft Niemann
- Department of Hematology; Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark
| | - R. Weinkove
- Wellington Blood & Cancer Centre; Capital & Coast District Health Board, Wellington, New Zealand and Cancer Immunotherapy Programme, Malaghan Institute of Medical Research; Wellington New Zealand
| | - S. Robinson
- Department of Medicine; Division of Hematology, QEII Health Sciences Center; Halifax NS Canada
| | - T.J. Kipps
- Moores Cancer Center; UC San Diego Health; San Diego CA United States
| | - S. Boettcher
- Department III of Internal Medicine; University Hospital Rostock; Rostock Germany
| | - E. Tausch
- Department III of Internal Medicine; Ulm University; Ulm Germany
| | - W.L. Schary
- Clinical Development Oncology; AbbVie Inc.; North Chicago IL United States
| | - B. Eichhorst
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - C. Wendtner
- Department of Hematology; Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine; Klinikum Schwabing Munich Germany
| | - A.W. Langerak
- Department of Immunology; Laboratory Medical Immunology, Erasmus MC; Rotterdam Netherlands
| | - K. Kreuzer
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - V. Goede
- Oncogeriatric Unit; Dept. of Geriatric Medicine, St. Marien Hospital; Cologne Germany
| | - S. Stilgenbauer
- Department III of Internal Medicine, Ulm University, Ulm, Germany and Department for Hematology, Oncology and Rheumatology; Saarland University Medical School; Homburg/Saar Germany
| | - M. Mobasher
- Product Development Oncology; Genentech, Inc.; South San Francisco CA United States
| | - M. Ritgen
- Department II of Internal Medicine; Campus Kiel, University of Schleswig-Holstein; Kiel Germany
| | - M. Hallek
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, CECAD (Cluster of Excellence on Cellular Stress Responses in Aging-Associated Diseases); University of Cologne; Cologne Germany
| |
Collapse
|
29
|
Al-Sawaf O, Lilienweiss E, Bahlo J, Robrecht S, Fink A, Patz M, Tandon M, Humphrey K, Jiang Y, Schary W, Porro Lurà M, Ritgen M, Tausch E, Stilgenbauer S, Eichhorst B, Fischer K, Hallek M, Kreuzer K. HIGH EFFICACY OF VENETOCLAX PLUS OBINUTUZUMAB IN PATIENTS WITH COMPLEX KARYOTYPE (CKT) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): A PROSPECTIVE ANALYSIS FROM THE CLL14 TRIAL. Hematol Oncol 2019. [DOI: 10.1002/hon.68_2629] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- O. Al-Sawaf
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - E. Lilienweiss
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - J. Bahlo
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - S. Robrecht
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - A. Fink
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - M. Patz
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - M. Tandon
- Clinical Development Oncology; Roche Products Limited; Welwyn Garden City United Kingdom
| | - K. Humphrey
- Clinical Development Oncology; Roche Products Limited; Welwyn Garden City United Kingdom
| | - Y. Jiang
- Oncology Biomarker Development; Genentech Inc.; South San Francisco CA United States
| | - W. Schary
- Clinical Development; Oncology, AbbVie Inc.; North Chicago IL United States
| | - M. Porro Lurà
- Pharmaceuticals Division, PDGo; F. Hoffmann-La Roche Ltd.; Basel Switzerland
| | - M. Ritgen
- Department II of Internal Medicine, Campus Kiel; University of Schleswig-Holstein; Kiel Germany
| | - E. Tausch
- Department III of Internal Medicine; Ulm University; Ulm Germany
| | - S. Stilgenbauer
- Department III of Internal Medicine, Ulm University, Ulm, Germany, and Department for Hematology, Oncology and Rheumatology; Saarland University Medical School; Homburg/Saar Germany
| | - B. Eichhorst
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - K. Fischer
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| | - M. Hallek
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn, University Hospital, Cologne, CECAD (Cluster of Excellence on Cellular Stress Responses in Aging-Associated Diseases); University of Cologne; Cologne Germany
| | - K. Kreuzer
- Department I of Internal Medicine and Center of Integrated Oncology Cologne Bonn; University Hospital; Cologne Germany
| |
Collapse
|
30
|
Lehr C, Skeans M, Dasenbrook E, Faro A, Fink A, Fernandez G, Valapour M. Including Cystic-Fibrosis-Specific Variables Improves Accuracy of the Lung Allocation Score. J Heart Lung Transplant 2019. [DOI: 10.1016/j.healun.2019.01.854] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
|
31
|
Munster P, Krischer J, Tamura R, Fink A, Bello-Matricaria L, Guilin M. Abstract GS5-01: A randomized community-based trial of an angiotensin converting enzyme inhibitor, lisinopril or a beta blocker, carvedilol for the prevention of cardiotoxicity in patients with early stage HER2-positive breast cancer receiving adjuvant trastuzumab. Cancer Res 2019. [DOI: 10.1158/1538-7445.sabcs18-gs5-01] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background:
Exposure to trastuzumab for one year is an integral part of therapy for patients with early stage HER2-positive breast cancer. Yet, cardiac side effects, particularly in patients who also receive anthracyclines require frequent monitoring and result in dose interruptions and discontinuation of trastuzumab. Prophylactic use of angiotensin converting enzyme (ACE) nhibitors or beta blockers (BB) may prevent cardiotoxicity associated with chemotherapy and trastuzumab.
Methods
A large community-based prospective double-blind, placebo-controlled trial, evaluated the rates of pre-specified cardiotoxicity in patients with early stage breast cancer treated with one year of trastuzumab. Cardiac events were followed for two years. Patients were randomized to simultaneously receive either the ACE inhibitor, lisinopril, or the BB, carvedilol, or placebo and were further stratified by anthracycline use to determine whether ACE inhibitors or BB can prevent trastuzumab-induced decrease in left ventricular ejection fraction (LVEF) and trastuzumab interruptions.
Results:
The study included 468 eligible patients (median age:51, BMI:27 kg/m2, baseline systolic BP: 126mmHg and LVEF :63 ± 6.29%) from 127 community-based practices, 189 patients received an anthracycline. For the entire study population and the non-anthracycline group, no difference in number of trastuzumab interruptions were seen. For patients receiving an anthracycline, cardiac event rates were higher in the placebo group (47%), and reduced in both the lisinopril (37%), and the carvedilol (31%) groups. Interruptions of trastuzumab were required in 23% patients on lisinopril and 20% on carvedilol compared to 40% on placebo (p=0.007). Changes in LVEF from baseline (least square means, SE) were significantly reduced with both carvedilol (-4.5 (0.8), p=0.008, and lisinopril (-4.0 (0.8), p=0.002) than placebo, (-7.7 (0.8). Cardiotoxicity-free survival was longer on both carvedilol (hazard ratio 0.49, 95% confidence intervals 0.27, 0.89, p=0.009) or lisinopril (HR 0.53, CI 0.30, 0.94, p=0.015).
Conclusions
In patients with HER2-positive breast cancer receiving trastuzumab and an anthracycline, both lisinopril and carvedilol during treatment reduced cardiotoxicity in patients, but not in those with non-anthracyline containing regimens. The use of lisinopril or carvedilol may allow the use of an anthracycline without compromising trastuzumab treatment in those who might benefit from an anthracycline.
Citation Format: Munster P, Krischer J, Tamura R, Fink A, Bello-Matricaria L, Guilin M. A randomized community-based trial of an angiotensin converting enzyme inhibitor, lisinopril or a beta blocker, carvedilol for the prevention of cardiotoxicity in patients with early stage HER2-positive breast cancer receiving adjuvant trastuzumab [abstract]. In: Proceedings of the 2018 San Antonio Breast Cancer Symposium; 2018 Dec 4-8; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2019;79(4 Suppl):Abstract nr GS5-01.
Collapse
Affiliation(s)
- P Munster
- University of California, San Francisco, CA; University of South Florida, Tampa, FL; University of Kentucky, Lexington, KY
| | - J Krischer
- University of California, San Francisco, CA; University of South Florida, Tampa, FL; University of Kentucky, Lexington, KY
| | - R Tamura
- University of California, San Francisco, CA; University of South Florida, Tampa, FL; University of Kentucky, Lexington, KY
| | - A Fink
- University of California, San Francisco, CA; University of South Florida, Tampa, FL; University of Kentucky, Lexington, KY
| | - L Bello-Matricaria
- University of California, San Francisco, CA; University of South Florida, Tampa, FL; University of Kentucky, Lexington, KY
| | - M Guilin
- University of California, San Francisco, CA; University of South Florida, Tampa, FL; University of Kentucky, Lexington, KY
| |
Collapse
|
32
|
Munster P, Krischer J, Tamura R, Bello-Matricaria L, Fink A, McCaskill-Stevens W, Guglin M. Randomized trial of lisinopril or carvedilol for the prevention of cardiotoxicity in patients with early stage HER2-positive breast cancer receiving trastuzumab. Ann Oncol 2018. [DOI: 10.1093/annonc/mdy270.188] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
33
|
Meier S, Gillon T, Mitter V, Fink A, Mueller M, Rau T, Von Wolff M, Kohl Schwartz A. Antibiotic treatment of chronic endometritis seems to preserve pregnancy in women with recurrent miscarriages or recurrent implantation failure. Geburtshilfe Frauenheilkd 2018. [DOI: 10.1055/s-0038-1670983] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022] Open
Affiliation(s)
- S Meier
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital and University of Bern, Bern, Schweiz
| | - T Gillon
- Department of Obstetrics and Gynecology, Bern University Hospital and University of Bern, Bern, Schweiz
| | - V Mitter
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital and University of Bern, Bern, Schweiz
| | - A Fink
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital and University of Bern, Bern, Schweiz
| | - M Mueller
- Department of Obstetrics and Gynecology, Bern University Hospital and University of Bern, Bern, Schweiz
| | - T Rau
- Institute of Pathology, University of Bern, Bern, Schweiz
| | - M Von Wolff
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital and University of Bern, Bern, Schweiz
| | - A Kohl Schwartz
- Division of Gynecological Endocrinology and Reproductive Medicine, Bern University Hospital and University of Bern, Bern, Schweiz
| |
Collapse
|
34
|
Fink A, Delidovich I, Palkovits R. Einfluss des Si/Al-Verhältnisses in Zeolithen auf die katalytische Aktivität bei der OME 3-5
-Herstellung. CHEM-ING-TECH 2018. [DOI: 10.1002/cite.201855088] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
- A. Fink
- RWTH Aachen Universität; Lehrstuhl für Heterogene Katalyse und Technische Chemie; Worringerweg 2 52074 Aachen Deutschland
| | - I. Delidovich
- RWTH Aachen Universität; Lehrstuhl für Heterogene Katalyse und Technische Chemie; Worringerweg 2 52074 Aachen Deutschland
| | - R. Palkovits
- RWTH Aachen Universität; Lehrstuhl für Heterogene Katalyse und Technische Chemie; Worringerweg 2 52074 Aachen Deutschland
| |
Collapse
|
35
|
Schumann N, Schröder SL, Roick J, Fink A, Richter M. „Jetzt muss ich mich damit auch noch rumärgern.“ Finanzielle Auswirkungen einer Krebserkrankung und daraus resultierende psychosoziale Belastungen – eine qualitative Studie aus Patientensicht. Psychother Psychosom Med Psychol 2018. [DOI: 10.1055/s-0038-1668027] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- N Schumann
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | - SL Schröder
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | - J Roick
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | - A Fink
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | - M Richter
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| |
Collapse
|
36
|
Fink A, Werner M, Fach EM. Soziale Ungleichheiten in der Versorgung von Personen mit Diabetes mellitus Typ 2. Eine qualitative Studie zur Exploration der Patientenperspektive. Psychother Psych Med 2018. [DOI: 10.1055/s-0038-1667930] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- A Fink
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | | | | |
Collapse
|
37
|
Markert J, Fach EM, Fink A, Richter M. Diagnosebezogene Unterschiede beim Zugang zur medizinischen Rehabilitation. Eine quantitative Analyse zu psychischen Beeinträchtigungen. Psychother Psychosom Med Psychol 2018. [DOI: 10.1055/s-0038-1667880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- J Markert
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | - EM Fach
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | - A Fink
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | - M Richter
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| |
Collapse
|
38
|
Schröder SL, Schumann N, Fink A, Richter M. Finanzielle Auswirkungen einer Krebserkrankung in Deutschland – eine qualitative Studie. Psychother Psychosom Med Psychol 2018. [DOI: 10.1055/s-0038-1668028] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- SL Schröder
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | - N Schumann
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | - A Fink
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | - M Richter
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| |
Collapse
|
39
|
Fink A, Gebhard B. Entwicklung und psychometrische Prüfung eines Instrumentes zur Messung sozialer Partizipation bei Jugendlichen. Psychother Psychosom Med Psychol 2018. [DOI: 10.1055/s-0038-1668046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
Affiliation(s)
- A Fink
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale), Deutschland
| | | |
Collapse
|
40
|
Faro A, Elbert A, Fink A, Wu R, Marshall B. P196 Breastfeeding and higher SES lead to better outcomes in children with CF. J Cyst Fibros 2018. [DOI: 10.1016/s1569-1993(18)30491-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
41
|
Abstract
PURPOSE The study examined the influence of individual blood pressure changes overtime on retinal vessel diameter and the latter's response to flicker light. METHODS The diameter of a retinal arterial and venous segment was measured continuously on-line with a Dynamic Vessel Analyzer in 20 patients twice (mean interval between examinations of 24 months). Eleven patients had no cardiovascular disease. Nine patients had arterial hypertension and were untreated at the time of the first measurement; at the time of the second measurement they were undergoing various antihypertensive therapies. Each test consisted of a 50-s baseline plus three 20-s periods of flicker stimulation followed by an 80-s period of observation. During the examinations the blood pressure was measured at 1-minute intervals. RESULTS In the hypertension group changes in the mean arterial blood pressure (MAP) correlated significantly with changes in the arterial baseline diameter (y = -0.1 - 0.37x, r =0.74, p (increase) <0.03). A comparison of the two measurements showed no such relationship in the group of cardiovascularly healthy subjects. The venous baseline and the arterial and venous flicker response did not change significantly in either group between the two measurements and showed no relationship to blood pressure changes. CONCLUSIONS In hypertensive subjects, long-term therapy-related changes in blood pressure induced a change in the arterial baseline by approximately +3.7 microm/-10 mmHg MAP. An influence of lowering MAP to the arterial flicker response could not be detected.
Collapse
Affiliation(s)
- E Nagel
- Technical University, Ilmenau, Germany.
| | | | | | | | | |
Collapse
|
42
|
Abstract
BACKGROUND In Germany, epidemiological information on Parkinson's disease (PD) is rare and outdated. Considering aging populations, current prevalences and incidence rates about this age-related disease would be important for adequate public health planning. METHODS We used newly available health claims data sets from the largest German health insurer dating 2004-2007 and 2007-2010 with an analysis population in the base years of 491 038 persons aged 50 and older. Quarter-specific information about ICD-10 diagnoses and PD drug prescriptions from the inpatient and outpatient sectors was used to validate PD cases. Estimations were presented for two validation strategies relying on repeated PD diagnoses (SIa) and on one PD diagnosis followed by at least one PD drug prescription (SIb). RESULTS The standardized prevalence was 797 (SIb) to 961/100 000 persons (SIa), showing an age-specific increase up to category 85-89 and a decline thereafter. The standardized incidence rate was 192 to 229/100 000 person-years with a similar age-specific shape. Prevalences and incidences rates were higher for men compared to women in regard to age. CONCLUSIONS Health claims data are found to be suitable for PD assessment using the repeated diagnoses or PD drug prescriptions as necessary criteria.
Collapse
Affiliation(s)
- M. Nerius
- German Center for Neurodegenerative Diseases (DZNE); Bonn Germany
- Rostock Center for the Study of Demographic Change; Rostock Germany
- Institute for Sociology and Demography; University of Rostock; Rostock Germany
| | - A. Fink
- German Center for Neurodegenerative Diseases (DZNE); Bonn Germany
- Rostock Center for the Study of Demographic Change; Rostock Germany
| | - G. Doblhammer
- German Center for Neurodegenerative Diseases (DZNE); Bonn Germany
- Rostock Center for the Study of Demographic Change; Rostock Germany
- Institute for Sociology and Demography; University of Rostock; Rostock Germany
- Max Planck Institute for Demographic Research; Rostock Germany
| |
Collapse
|
43
|
Unterrainer HF, Hiebler M, Ragger K, Froehlich L, Koschutnig K, Schoeggl H, Kapfhammer HP, Papousek I, Weiss EM, Fink A. White matter integrity in polydrug users in relation to attachment and personality: a controlled diffusion tensor imaging study. Brain Imaging Behav 2017; 10:1096-1107. [PMID: 26542619 DOI: 10.1007/s11682-015-9475-4] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
Abstract
The relationship between substance use disorders (SUD) and brain deficits has been studied extensively. However, there is still a lack of research focusing on the structural neural connectivity in long-term polydrug use disorder (PUD). Since a deficiency in white matter integrity has been reported as being related to various parameters of increased psychopathology, it might be considered an aggravating factor in the treatment of SUD. In this study we compared two groups of PUD inpatients (abstinent: n = 18, in maintenance treatment: n = 15) to healthy controls (n = 16) with respect to neural connectivity in white matter, and their relation to behavioral parameters of personality factors/organization and attachment styles. Diffusion Tensor Imaging was used to investigate white matter structure. Compared with healthy controls, the PUD patients showed reduced fractional anisotropy (FA) and increased radial diffusivity (RD) mainly in the superior fasciculus longitudinalis and the superior corona radiata. These findings suggest diminished neural connectivity as a result of myelin pathology in PUD patients. In line with our assumptions, we observed FA in the biggest cluster as negatively correlated with anxious attachment (r = 0.36, p < 0.05), personality dysfunctioning (r = -0.41; p < 0.01) as well positively correlated with personality factors Openness (r = 0.34; p < 0.05) and Agreeableness (r = 0.28; p < 0.05). Correspondingly these findings were inversely mirrored by RD. Further research employing enhanced samples and addressing longitudinally neuronal plastic effects of SUD treatment in relation to changes in personality and attachment is recommended.
Collapse
Affiliation(s)
- H F Unterrainer
- University of Graz, Institute of Psychology, BioTechMed-Graz, Graz, Austria. .,Center for Integrative Addiction Research (Grüner Kreis Society), Vienna, Austria. .,University Clinic of Psychiatry, Medical University, Graz, Austria. .,Karl-Franzens-University Graz, Universitätsplatz 2, 8010, Graz, Austria.
| | - M Hiebler
- University of Graz, Institute of Psychology, BioTechMed-Graz, Graz, Austria
| | - K Ragger
- University of Graz, Institute of Psychology, BioTechMed-Graz, Graz, Austria
| | - L Froehlich
- University of Graz, Institute of Psychology, BioTechMed-Graz, Graz, Austria
| | - K Koschutnig
- University of Graz, Institute of Psychology, BioTechMed-Graz, Graz, Austria
| | - H Schoeggl
- University Clinic of Psychiatry, Medical University, Graz, Austria
| | - H P Kapfhammer
- University Clinic of Psychiatry, Medical University, Graz, Austria
| | - I Papousek
- University of Graz, Institute of Psychology, BioTechMed-Graz, Graz, Austria
| | - E M Weiss
- University of Graz, Institute of Psychology, BioTechMed-Graz, Graz, Austria
| | - A Fink
- University of Graz, Institute of Psychology, BioTechMed-Graz, Graz, Austria
| |
Collapse
|
44
|
Schröder SL, Fink A, Hoffmann L, Schumann N, Martin O, Richter M. Sozioökonomische Unterschiede in den Wegen zur Diagnostik der koronaren Herzkrankheit – einequalitative Studie aus Patientensicht. Das Gesundheitswesen 2017. [DOI: 10.1055/s-0037-1605663] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- SL Schröder
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale)
| | - A Fink
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale)
| | - L Hoffmann
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale)
| | - N Schumann
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale)
| | - O Martin
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale)
| | - M Richter
- Martin-Luther-Universität Halle-Wittenberg, Medizinische Fakultät, Institut für Medizinische Soziologie, Halle (Saale)
| |
Collapse
|
45
|
Yang E, William W, Fayette J, Zhang W, Fink A, Lin A, Deutsch E. Phase 1b trial of LY2606368 in combination with chemoradiation in patients with locally advanced head and neck squamous cell cancer. Ann Oncol 2016. [DOI: 10.1093/annonc/mdw376.71] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
46
|
Fink A, Gebhard B, Erdwiens S, Haddenhorst L, Nowak S. Reliability of the German version of the Children's Assessment of Participation and Enjoyment (CAPE) and Preferences for Activities of Children (PAC). Child Care Health Dev 2016; 42:683-91. [PMID: 27273161 DOI: 10.1111/cch.12360] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/20/2015] [Revised: 03/23/2016] [Accepted: 05/07/2016] [Indexed: 11/30/2022]
Abstract
BACKGROUND The introduction of the International Classification of Functioning, Disabilities and Health of the World Health Organization in 2001 made social participation a major rehabilitation outcome and the ultimate goal of rehabilitation services. There is no available instrument to measure the youth participation in leisure activities apart from asking the youth themselves. The goal of this study was to present a German version of the Children's Assessment of Participation and Enjoyment and Preferences for Activities of Children (CAPE/PAC). METHODS The CAPE/PAC questionnaire was translated into German, a cultural adaptation process was designed and a reliability study was conducted. One hundred and fifty-two youths with and without disabilities, with a mean age of 15.2 years (standard deviation 1.7), participated in the study. The participants completed CAPE and PAC twice within 4 weeks. Reliability was examined by intraclass correlation coefficients, standard error of measurement, smallest detectable change and Cronbach's alpha. RESULTS The absolute values of participation differ between the typically developed youth group and those with impairments; the reliability of the CAPE/PAC is comparable in both groups. Intraclass correlation coefficients ranged from 0.43 to 0.74 for the CAPE and from 0.71 to 0.83 for the PAC in all participants. The alpha values for internal consistency ranged from 0.42 to 0.82 for the CAPE and from 0.65 to 0.92 for the PAC. CONCLUSIONS The German version of the PAC showed satisfactory reliability; however, reliability was not satisfactory for all scores of the CAPE, but comparable with versions in other languages. The need for newly developed participation measurements requires further discussion.
Collapse
Affiliation(s)
- A Fink
- Institute of Medical Sociology, Medical Faculty, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany
| | - B Gebhard
- Faculty of Business and Social Sciences, University of Applied Sciences Nordhausen, Nordhausen, Germany
| | - S Erdwiens
- University of Oldenburg, Oldenburg, Germany
| | - L Haddenhorst
- University of Applied Sciences Berlin, Berlin, Germany
| | - S Nowak
- West Saxon University of Applied Sciences of Zwickau, Zwickau, Germany
| |
Collapse
|
47
|
Malinovic A, Fink A, Lewis AJ, Unterrainer HF. Dimensions of Religious/Spiritual Well-Being in Relation to Personality and Stress Coping: Initial Results From Bosnian Young Adults. Journal of Spirituality in Mental Health 2016. [DOI: 10.1080/19349637.2015.1059301] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
48
|
Martin O, Fink A. Kommunikative Fertigkeiten mit E-Learning? Gesundheitswesen 2015. [DOI: 10.1055/s-0035-1563122] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
49
|
Fink A, Gebhard B, Nowak S. Entwicklung und Prüfung der deutschsprachigen Version der kanadischen Fragebögen „Children's Assessment of Participation and Enjoyment (CAPE)“ und „Preferences for Activities of Children (PAC)“. Gesundheitswesen 2015. [DOI: 10.1055/s-0035-1563320] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
50
|
Schröder SL, Fink A, Richter M. Wie soziale Ungleichheiten den Behandlungs- und Versorgungsverlauf bei koronarer Herzkrankheit beeinflussen – eine qualitative Studie aus Sicht älterer Patienten. Gesundheitswesen 2015. [DOI: 10.1055/s-0035-1563269] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|